Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aridis Pharmaceuticals Inc (NQ: ARDS )

0.6605 -0.0095 (-1.42%)
Streaming Delayed Price Updated: 2:49 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 380,691
Open 0.6900
Bid (Size) 0.6605 (22)
Ask (Size) 0.6695 (2)
Prev. Close 0.6700
Today's Range 0.6570 - 0.6900
52wk Range 0.5722 - 2.940
Shares Outstanding 17,701,592
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Dow Surges Over 100 Points; World Acceptance Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday. The Dow traded up 0.35% to 33,863.38 while the NASDAQ rose 1.33% to 11,463.77. The S&P 500... 
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million. 
Via Benzinga

Performance

YTD
-55.97%
-55.97%
1 Month
-55.97%
-55.97%
3 Month
-32.60%
-32.60%
6 Month
-69.98%
-69.98%
1 Year
-67.14%
-67.14%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
US GDP Rises 2.9% In Q4; Crude Oil Up Over 1%
Via Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why LogicMark Shares Are Trading Lower By Around 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
From Aridis Pharmaceuticals, Inc.
Via Globe NewsWire
Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
From Aridis Pharmaceuticals, Inc.
Via Globe NewsWire
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
From Aridis Pharmaceuticals, Inc.
Via Globe NewsWire
Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients
From Aridis Pharmaceuticals, Inc.
Via Globe NewsWire
Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases
From Aridis Pharmaceuticals, Inc.
Via Globe NewsWire
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
From Aridis Pharmaceuticals, Inc.
Via Globe NewsWire
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.